Adventitial sheathotomy for decompression of recent onset branch retinal vein occlusion

Rouic, Jean-François Le; Bejjani, R.A.; Rumen, F; Caudron, Christophe; Bettembourg, O.; Renard, G; Chauvaud, D

doi:10.1007/s004170100360

Cited by 44 publications

(26 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This has been expressed by authors reporting results of sheathotomy. [8][9][10][11][12][13][14][15][16] The possibility of rupture of one of the vessels may be frightening and dissuasive for surgeons. What should be known is whether this new surgical procedure is worth performing.…”

Section: Discussionmentioning

confidence: 99%

“…To analyse and compare the studies on sheathotomy is difficult because of differences and variations of methodology. [8][9][10][11][12][13][14][15][16][21][22][23][24][25][26][27][28][29][30] No control group that has similar conditions could have been created in the majority of the reported studies. Some case reports have shown favourable results while others have not.…”

Section: Discussionmentioning

confidence: 99%

“…8 Several authors have attempted to perform adventitial sheathotomy to manage macular oedema due to BRVO. [8][9][10][11][12][13][14][15][16] In our study, we analysed our results in patients who were treated with arteriovenous adventitial sheathotomy for the treatment of macular oedema associated with BRVO.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Evaluation of arteriovenous crossing sheathotomy for decompression of branch retinal vein occlusion

Avcı

İnan

Kaderli

2006

Eye

View full text Add to dashboard Cite

Purpose To report the effects of arteriovenous adventitial sheathotomy on anatomical and functional improvements in patients with macular oedema due to branch retinal vein occlusion (BRVO). Methods Pars plana vitrectomy and arteriovenous sheathotomy was performed on 11 patients with BRVO who had vision loss due to macular oedema. Ten patients with macular oedema due to BRVO and who have been treated with grid laser photocoagulation were included in the control group. The measurement of visual acuity with ETDRS chart was taken preoperatively and at 1, 3, 6, and 9 months follow-up in the study group and at 1, 3, 6, and 9 months after grid laser in the control group. Results The mean preoperative logMAR visual acuity was 0.8470.3 in the surgical group and 1.0670.4 in the control group. The postoperative mean logMAR visual acuity was 0.4170.2, 0.4070.2, 0.4070.3, and 0.3670.3 at 1, 3, 6, and 9 months follow-up, respectively. In the control group the postlaser mean logMAR visual acuity was 0. 9270.3, 0.8770.4, 0.8570.3, and 0.8270.3 at 1, 3, 6, and 9 months follow-up, respectively. The improvements of visual acuity in both groups were statistically significant when compared to pretreatment (P ¼ 0.003 and P ¼ 0.007 at 9 months in the study and control group, respectively). Conclusion Arteriovenous sheathotomy for decompression of BRVO in patients who have vision loss due to macular oedema was safe and effective for anatomical and functional improvement and resulted in significantly better visual outcomes than a matched control group of laser-treated eyes.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Evaluation of arteriovenous crossing sheathotomy for decompression of branch retinal vein occlusion

Avcı

İnan

Kaderli

2006

Eye

View full text Add to dashboard Cite

show abstract

“…A decompression at the arteriovenous crossing site can theoretically be effective in treating the pathogenetic mechanism by improving the venous blood flow. Even though the data are not univocal, overall, the majority of the reports have suggested that this surgical approach is beneficial in improving VA and reducing ME [75,76,77,78]. Nevertheless, some studies comparing vitrectomy alone with vitrectomy associated with sheathotomy have pointed out the absence of any difference in the clinical outcomes [79, 80].…”

Section: Treatmentmentioning

confidence: 99%

Branch Retinal Vein Occlusion: Classification and Treatment

Parodi

Bandello²

2009

Ophthalmologica

View full text Add to dashboard Cite

Branch retinal vein occlusion (BRVO) refers to a heterogeneous group of disorders with different clinical aspects, courses, and probably therapy. Depending on the site of the arteriovenous crossing, we can roughly divide BRVO into 3 main groups: major BRVO, hemispheric retinal vein occlusion, and macular BRVO. Main treatment options include laser treatment, corticosteroid administration, anti-VEGF drugs, and sheathotomy with or without vitrectomy. Laser photocoagulation, as demonstrated by the Branch Vein Occlusion Study, represents the gold standard for the treatment of macular edema and ocular neovascularization following BRVO. The limited functional outcomes achievable by means of laser treatment have prompted researchers to try alternative options, with varying results. The recent introduction of combined therapies for macular edema may provide a superior approach in an attempt to improve and stabilize visual acuity over a long-term follow-up.

show abstract

“…Several small, uncontrolled series have shown good results in improving macular edema and macular perfusion. However, others have reported a lack of efficacy of this procedure (Le Rouic et al, 2001;Cahill et al, 2003).…”

Section: Management Of Branch Retinal Vein Occlusionmentioning

confidence: 99%